David Porciani, University of Missouri-Columbia (IMAGE)

University of Missouri-Columbia

David Porciani, University of Missouri-Columbia

Caption

David Porciani and his team demonstrated that specialized nucleic acid-based nanostructures could be used to target cancer cells while bypassing normal cells.

Credit

Erica Overfelt, Bond Life Sciences Center

Usage Restrictions

None

License

Licensed content

Disclaimer: AAAS and EurekAlert! are not responsible for the accuracy of news releases posted to EurekAlert! by contributing institutions or for the use of any information through the EurekAlert system.